- Home
- WAT vs XPO Comparison
WAT vs XPO Comparison
Compare WAT & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAT
- XPO
- Stock Information
- Founded
- WAT 1958
- XPO 2000
- Country
- WAT United States
- XPO United States
- Employees
- WAT N/A
- XPO N/A
- Industry
- WAT Biotechnology: Laboratory Analytical Instruments
- XPO Transportation Services
- Sector
- WAT Industrials
- XPO Consumer Discretionary
- Exchange
- WAT Nasdaq
- XPO Nasdaq
- Market Cap
- WAT 17.4B
- XPO 16.0B
- IPO Year
- WAT 1995
- XPO N/A
- Fundamental
- Price
- WAT $412.54
- XPO $140.35
- Analyst Decision
- WAT Buy
- XPO Strong Buy
- Analyst Count
- WAT 13
- XPO 18
- Target Price
- WAT $379.00
- XPO $146.44
- AVG Volume (30 Days)
- WAT 657.5K
- XPO 1.4M
- Earning Date
- WAT 11-04-2025
- XPO 10-30-2025
- Dividend Yield
- WAT N/A
- XPO N/A
- EPS Growth
- WAT 3.82
- XPO N/A
- EPS
- WAT 10.88
- XPO 2.78
- Revenue
- WAT $3,105,638,000.00
- XPO $8,068,000,000.00
- Revenue This Year
- WAT $7.12
- XPO $1.30
- Revenue Next Year
- WAT $6.22
- XPO $3.90
- P/E Ratio
- WAT $37.96
- XPO $50.36
- Revenue Growth
- WAT 6.90
- XPO N/A
- 52 Week Low
- WAT $275.05
- XPO $85.06
- 52 Week High
- WAT $423.56
- XPO $161.00
- Technical
- Relative Strength Index (RSI)
- WAT 79.36
- XPO 58.35
- Support Level
- WAT $371.57
- XPO $124.82
- Resistance Level
- WAT $391.79
- XPO $138.07
- Average True Range (ATR)
- WAT 10.05
- XPO 5.52
- MACD
- WAT 1.55
- XPO -0.07
- Stochastic Oscillator
- WAT 99.18
- XPO 84.70
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.